QLT Share Price

Open 2.69 Change Price %
High 2.70 1 Day -0.05 -1.89
Low 2.31 1 Week 0.00 0.00
Close 2.59 1 Month 0.00 0.00
Volume 5150 1 Year -1.12 -30.19
52 Week High 3.78
52 Week Low 1.60
QLT Important Levels
Resistance 2 2.95
Resistance 1 2.80
Pivot 2.53
Support 1 2.38
Support 2 2.23
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
BBD-B 2.63 -1.87%
BTO 3.76 2.73%
BTO 3.76 2.73%
SC 60.83 -0.44%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
BX 0.90 18.42%
BX 0.90 18.42%
TC 57.03 17.51%
TC 57.03 17.51%
CDH 0.54 14.89%
ANX 0.08 14.29%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
GLG 0.28 -12.50%
CTU-A 0.19 -9.52%
GGA 0.13 -7.14%
DEJ 0.14 -6.67%
DEJ 0.14 -6.67%
TDG 3.13 -6.57%
TDG 3.13 -6.57%
ORA 1.85 -6.09%
ORA 1.85 -6.09%
More..

QLT Inc (TSE: QLT)

QLT Technical Analysis 3
As on 30th Nov 2016 QLT Share Price closed @ 2.59 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.46 & Buy for SHORT-TERM with Stoploss of 2.42 we also expect STOCK to react on Following IMPORTANT LEVELS.
QLT Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
QLT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.qltinc.com
QLT Address
QLT
887 Great Northern Way
Suite 101
Vancouver, BC V5T 4T5
Canada
Phone: 604-707-7000
Fax: 604-707-7001
QLT Latest News
CCI, ADX, and Williams %R Review for Novelion Therapeutics Inc. (NVLN)   Yankee Analysts   - 20th Jan 17
Markets End Mostly Higher, How Did This Stock Fare: Novelion Therapeutics Inc ...   Wall Street Beacon   - 14th Jan 17
Novelion Therapeutics Inc. (NASDAQ:NVLN) Files An 8-K Results of Operations ...   Market Exclusive   - 09th Jan 17
Novelion Therapeutics Completes Reverse Stock Split   GlobeNewswire (press release)   - 17th Dec 16
Novelion Therapeutics' Subsidiary Launches JUXTAPID® (lomitapide) in Japan   GlobeNewswire (press release)   - 16th Dec 16
Aegerion Pharmaceuticals, a Subsidiary of Novelion Therapeutics, Enters into ...   GlobeNewswire (press release)   - 05th Dec 16
Novelion Therapeutics Subsidiary, Aegerion Pharmaceuticals, Enters Into ...   GlobeNewswire (press release)   - 05th Dec 16
News Novelion Therapeutics Inc.NVLN   Wall Street Journal   - 30th Nov 16
Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT ...   GlobeNewswire (press release)   - 29th Nov 16
Aegerion, QLT Ink Merger Deal to Form Novelion Therapeutics   Yahoo News   - 17th Jun 16
Interactive Technical Analysis Chart QLT Inc ( QLT TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on QLT Inc
QLT Business Profile
QLT Inc., a biotechnology company, develops and commercializes ocular products that address the unmet medical needs of patients and clinicians worldwide. It focuses on the development of QLT091001, a synthetic retinoid compound, which is in phase Ib retreatment clinical trials for the treatment of leber congenital amaurosis and retinitis pigmentosa; phase Ib clinical trials for the treatment of Retinitis Pigmentosa with autosomal dominant mutation in RPE65; and phase IIa clinical trials for the treatment of impaired dark adaptation. The company was founded in 1981 and is headquartered in Vancouver, Canada.